241 related articles for article (PubMed ID: 21044013)
21. Identification, characterization and biological significance of very small embryonic-like stem cells (VSELs) in regenerative medicine.
Feng G; Cui J; Zheng Y; Han Z; Xu Y; Li Z
Histol Histopathol; 2012 Jul; 27(7):827-33. PubMed ID: 22648539
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.
Zhang Y; Hu W; Ma K; Zhang C; Fu X
Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578
[TBL] [Abstract][Full Text] [Related]
23. Breakdown of the potentiality principle and its impact on global stem cell research.
Testa G; Borghese L; Steinbeck JA; Brüstle O
Cell Stem Cell; 2007 Aug; 1(2):153-6. PubMed ID: 18371347
[TBL] [Abstract][Full Text] [Related]
24. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells.
Batta K; Florkowska M; Kouskoff V; Lacaud G
Cell Rep; 2014 Dec; 9(5):1871-1884. PubMed ID: 25466247
[TBL] [Abstract][Full Text] [Related]
25. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
[TBL] [Abstract][Full Text] [Related]
26. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
[TBL] [Abstract][Full Text] [Related]
27. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.
Marion RM; Strati K; Li H; Tejera A; Schoeftner S; Ortega S; Serrano M; Blasco MA
Cell Stem Cell; 2009 Feb; 4(2):141-54. PubMed ID: 19200803
[TBL] [Abstract][Full Text] [Related]
28. In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination.
Smith MJ; Webber BR; Mohtashami M; Stefanski HE; Zúñiga-Pflücker JC; Blazar BR
Stem Cells; 2015 Nov; 33(11):3174-80. PubMed ID: 26227158
[TBL] [Abstract][Full Text] [Related]
29. Generation of novel rat and human pluripotent stem cells by reprogramming and chemical approaches.
Li W; Ding S
Methods Mol Biol; 2010; 636():293-300. PubMed ID: 20336530
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms that mediate stem cell self-renewal and differentiation.
Zhang H; Wang ZZ
J Cell Biochem; 2008 Feb; 103(3):709-18. PubMed ID: 17647265
[TBL] [Abstract][Full Text] [Related]
31. Skin cells reprogrammed to be stem cells.
Kuehn BM
JAMA; 2008 Jan; 299(1):26. PubMed ID: 18167399
[No Abstract] [Full Text] [Related]
32. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
[TBL] [Abstract][Full Text] [Related]
33. [Breakthrough in research on pluripotent stem cells and their application in medicine].
Valdimarsdóttir G; Richter A
Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
[TBL] [Abstract][Full Text] [Related]
34. Large scale production of stem cells and their derivatives.
Zweigerdt R
Adv Biochem Eng Biotechnol; 2009; 114():201-35. PubMed ID: 19513633
[TBL] [Abstract][Full Text] [Related]
35. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
Yoshida Y; Yamanaka S
Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
[No Abstract] [Full Text] [Related]
36. Stem cells and blastema cells.
Tsonis PA
Curr Stem Cell Res Ther; 2008 Jan; 3(1):53-4. PubMed ID: 18220923
[TBL] [Abstract][Full Text] [Related]
37. Defining Human Pluripotency.
Yilmaz A; Benvenisty N
Cell Stem Cell; 2019 Jul; 25(1):9-22. PubMed ID: 31271751
[TBL] [Abstract][Full Text] [Related]
38. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
39. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
Yamakawa H; Ieda M
Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
[TBL] [Abstract][Full Text] [Related]
40. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
